| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
956,580,000 |
| Market
Cap: |
741.78(B) |
| Last
Volume: |
4,111,096 |
Avg
Vol: |
3,320,913 |
| 52
Week Range: |
$713.71 - $960.02 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 412 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
2,250 |
883,250 |
1,361,732 |
5,177,176 |
| Total Sell Value |
$1,652,960 |
$2,147,483,647 |
$2,147,483,647 |
$2,147,483,647 |
| Total People Sold |
2 |
4 |
4 |
6 |
| Total Sell Transactions |
2 |
12 |
23 |
74 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Luciano Juan R |
Director |
– • – |
2025-06-16 |
4 |
A |
$807.58 |
$14,834 |
D/D |
18 |
16,362 |
|
- |
|
| Hedley Mary Lynne |
Director |
– • – |
2025-06-16 |
4 |
A |
$807.58 |
$9,916 |
D/D |
12 |
1,960 |
|
- |
|
| Alvarez Ralph |
Director |
– • – |
2025-06-16 |
4 |
A |
$807.58 |
$11,750 |
D/D |
15 |
54,979 |
|
- |
|
| Greene Gabrielle E |
Director |
– • – |
2025-06-16 |
4 |
A |
$807.58 |
$4,959 |
D/D |
6 |
2,580 |
|
- |
|
| Fyrwald J Erik |
Director |
– • – |
2025-06-16 |
4 |
A |
$807.58 |
$9,916 |
D/D |
12 |
73,000 |
|
- |
|
| Custer Kenneth L. |
EVP & President, Card Met Hlth |
• – – |
2025-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,328 |
|
6% |
|
| Zakrowski Donald A |
SVP, Finance, & CAO |
• – – |
2025-05-27 |
4 |
AS |
$716.41 |
$716,410 |
D/D |
(1,000) |
4,840 |
|
7% |
|
| Fyrwald J Erik |
Director |
– • – |
2025-05-19 |
4 |
A |
$755.11 |
$9,917 |
D/D |
13 |
72,852 |
|
- |
|
| Hedley Mary Lynne |
Director |
– • – |
2025-05-19 |
4 |
A |
$755.11 |
$9,917 |
D/D |
13 |
1,944 |
|
- |
|
| Greene Gabrielle E |
Director |
– • – |
2025-05-19 |
4 |
A |
$755.11 |
$4,958 |
D/D |
7 |
2,569 |
|
- |
|
| Luciano Juan R |
Director |
– • – |
2025-05-19 |
4 |
A |
$755.11 |
$14,833 |
D/D |
20 |
16,314 |
|
- |
|
| Alvarez Ralph |
Director |
– • – |
2025-05-19 |
4 |
A |
$755.11 |
$11,750 |
D/D |
16 |
54,863 |
|
- |
|
| Yuffa Ilya |
EVP & President, LLY Intl |
• – – |
2025-05-14 |
4 |
AS |
$749.24 |
$936,550 |
D/D |
(1,250) |
27,510 |
|
8% |
|
| Hakim Anat |
EVP, GC & Secretary |
• – – |
2025-05-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,875 |
10,963 |
|
- |
|
| Fyrwald J Erik |
Director |
– • – |
2025-04-21 |
4 |
A |
$818.02 |
$9,917 |
D/D |
12 |
72,839 |
|
- |
|
| Greene Gabrielle E |
Director |
– • – |
2025-04-21 |
4 |
A |
$818.02 |
$4,958 |
D/D |
6 |
2,562 |
|
- |
|
| Hedley Mary Lynne |
Director |
– • – |
2025-04-21 |
4 |
A |
$818.02 |
$9,917 |
D/D |
12 |
1,931 |
|
- |
|
| Luciano Juan R |
Director |
– • – |
2025-04-21 |
4 |
A |
$818.02 |
$14,833 |
D/D |
18 |
16,294 |
|
- |
|
| Alvarez Ralph |
Director |
– • – |
2025-04-21 |
4 |
A |
$818.02 |
$11,750 |
D/D |
14 |
54,847 |
|
- |
|
| Greene Gabrielle E |
Director |
– • – |
2025-03-17 |
4 |
A |
$824.76 |
$4,958 |
D/D |
6 |
2,556 |
|
- |
|
| Alvarez Ralph |
Director |
– • – |
2025-03-17 |
4 |
A |
$824.76 |
$11,750 |
D/D |
14 |
54,833 |
|
- |
|
| Hedley Mary Lynne |
Director |
– • – |
2025-03-17 |
4 |
A |
$824.76 |
$9,917 |
D/D |
12 |
1,919 |
|
- |
|
| Fyrwald J Erik |
Director |
– • – |
2025-03-17 |
4 |
A |
$824.76 |
$9,917 |
D/D |
12 |
72,827 |
|
- |
|
| Luciano Juan R |
Director |
– • – |
2025-03-17 |
4 |
A |
$824.76 |
$14,833 |
D/D |
18 |
16,276 |
|
- |
|
| Zakrowski Donald A |
SVP, Finance, & CAO |
• – – |
2025-03-13 |
4 |
AS |
$818.24 |
$818,240 |
D/D |
(1,000) |
5,840 |
|
-3% |
|
1422 Records found
|
|
Page 1 of 57 |
|
|
19.67 (2.47%) 
